FEBRUARY 11, 2012

Exclusive Headlines

BERKELEY, CA (UroToday.com) - Pelvic organ prolapse (POP) occurs in up to 50% of parous women and the lifetime risk of requiring surgery for POP is more than 10%.

see full text

BERKELEY, CA (UroToday.com) - Urothelial cancer is a chemotherapy-sensitive malignancy, with the regimen of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) until recently considered to be the first choice for chemotherapy, however its adverse effects and poor long-term outcome

see full text

BERKELEY, CA (UroToday.com) - Circulating tumor cells (CTC) in prostate cancer represent a new so-called biomarker.

see full text
Bladder Cancer
« Start  Prev  1 234NextEnd»
European Urology - Radical Cystectomy – Often Too Late? Yes, But … Print E-mail
Thu, 23 November 2006

Last Updated ( Thu, 30 November 2006 )

Login to read more...
European Urology - Thoughts on Delaying Cystectomy Print E-mail
Thu, 23 November 2006

Last Updated ( Thu, 30 November 2006 )

Login to read more...
European Urology - Delay in the Surgical Treatment of Bladder Cancer and Survival: Systematic Review of the Literature Print E-mail
Thu, 23 November 2006

Last Updated ( Thu, 30 November 2006 )

Login to read more...
European Urology - Supra-ampullar Cystectomy and Ileal Neobladder Print E-mail
Thu, 23 November 2006

Last Updated ( Thu, 30 November 2006 )

Login to read more...
European Urology - Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage Print E-mail
Thu, 23 November 2006

Last Updated ( Thu, 30 November 2006 )

Login to read more...
European Urology - Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: Report of Seven New Cases Print E-mail
Tue, 24 October 2006

Last Updated ( Wed, 01 November 2006 )

Login to read more...
European Urology - Elevated Microsatellite Instability at Selected Tetranucleotide Repeats does not Correlate with Clinicopathologic Features of Bladder Cancer Print E-mail
Thu, 21 September 2006

Last Updated ( Tue, 03 October 2006 )

Login to read more...
European Urology - Focal S100A4 Protein Expression Is an Independent Predictor of Development of Metastatic Disease in Cystectomized Bladder Cancer Patients Print E-mail
Thu, 21 September 2006

Last Updated ( Tue, 03 October 2006 )

Login to read more...
European Urology - Foreseeing Cancer Metastases Print E-mail
Wed, 20 September 2006

Last Updated ( Tue, 03 October 2006 )

Login to read more...
European Urology - Should Bladder Biopsies be Performed Routinely after Bacillus Calmette-Guérin Treatment for High-Risk Superficial Transitional Cell Cancer of the Bladder? Print E-mail
Fri, 01 September 2006

Last Updated ( Mon, 09 October 2006 )

Login to read more...
« Start  Prev  1 234NextEnd»
Share |

Featured Conference

XXXIII Brazilian Congress of Urology

November 22 - 26, 2011
Santa Catarina, Brazil

29th World Congress of Endourology & SWL

November 30 - December 3, 2011

Kyoto, Japan

Upcoming Conference

GU Cancers Symposium 2012

February 2 - 4, 2012

San Francisco Marriott Marquis
San Francisco, CA USA

Prostate cancer session highlights sponsored by Bristol-Myers Squibb